Circumvent the Tariff challenges with an agile supply chain Consulting
Supply Chain Ecosystem Analysis now part of DBMR Reports
Middle East Africa Ophthalmology Devices Market
Market Size in USD Billion
CAGR :
%
USD
3.62 Billion
USD
5.06 Billion
2024
2032
Forecast Period
2025 –2032
Market Size(Base Year)
USD
3.62 Billion
Market Size (Forecast Year)
USD
5.06 Billion
CAGR
4.30
%
Major Markets Players
Alcon Inc. (Switzerland)
Bausch + Lomb (U.S.)
Johnson & Johnson and its affiliates. (U.S.)
Carl Zeiss Meditec AG (Germany)
EssilorLuxottica (France)
Middle East and Africa Ophthalmology Devices Market Segmentation, By Product Type (Vision Care Devices, Surgery Devices and Diagnostic and Monitoring Devices), Application (Vision Care, Ophthalmic Woundcare, Cataract Surgery, Oculoplastics and Others), End User (Hospitals, Diagnosis Clinics, Franchise Optical Stores, Eye Research Institutes, and Government Agencies and Academics)- - Industry Trends and Forecast to 2032
Middle East and Africa Ophthalmology Devices Market Size
The Middle East and Africa Ophthalmology Devices Market size was valued at USD 3.62 billion in 2024 and is expected to reach USD 5.06 billion by 2032,at a CAGR of 4.30% during the forecast period
The market growth is largely fueled by the increasing prevalence of eye disorders such as cataracts, glaucoma, and age-related macular degeneration, coupled with rising awareness regarding early diagnosis and treatment. In addition, continuous technological advancements, including the integration of artificial intelligence (AI) and advanced imaging techniques, are enhancing diagnostic accuracy and treatment outcomes, driving the demand for ophthalmology devices globally
Furthermore, the growing adoption of minimally invasive surgical procedures and the rising preference for advanced ophthalmic equipment in hospitals and specialty clinics are establishing ophthalmology devices as essential components in modern eye care. These converging factors are accelerating the uptake of ophthalmology devices solutions, thereby significantly boosting the industry's growth
Middle East and Africa Ophthalmology Devices Market Analysis
Ophthalmology devices, encompassing diagnostic, monitoring, and surgical instruments, are essential components in modern eye care and vision correction practices, both in hospitals and specialty clinics. Their adoption is driven by rising incidences of cataracts, glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD), coupled with the growing demand for minimally invasive procedures and precision-based diagnostics
The escalating demand for ophthalmology devices is primarily fueled by an aging global population, increasing prevalence of chronic eye diseases, rapid technological advancements such as AI-enabled diagnostics, and a strong shift toward outpatient and home-based ophthalmic monitoring solutions
Saudi Arabia dominated the Middle East and Africa Ophthalmology Devices Market with the largest revenue share of 47.7% in 2024, driven by advanced healthcare infrastructure, high adoption of digital ophthalmic technologies, and a strong presence of key industry players. The country has witnessed substantial growth in ophthalmology device installations across hospitals, specialized eye clinics, and diagnostic center
The U.A.E. is expected to be the fastest growing country in the Middle East and Africa Ophthalmology Devices Market during the forecast period, with a CAGR from 2025 to 2032. This growth is fueled by increasing healthcare investments, modernization of hospitals and clinics, and adoption of advanced ophthalmic diagnostic and surgical devices
The Diagnostic and Monitoring Devices segment dominated the largest market revenue share of 46.7% in 2024, driven by the growing prevalence of eye disorders such as glaucoma, cataract, and diabetic retinopathy which require continuous monitoring and early-stage detection
Report Scope and Middle East and Africa Ophthalmology Devices Market Segmentation
Attributes
Middle East and Africa Ophthalmology Devices Key Market Insights
Segments Covered
By Product Type: Vision Care Devices, Surgery Devices, and Diagnostic and Monitoring Devices
By Application: Vision Care, Ophthalmic Woundcare, Cataract Surgery, Oculoplastics, and Others
By End User: Hospitals, Diagnosis Clinics, Franchise Optical Stores, Eye Research Institutes, and Government Agencies and Academics
Al Shidhani Medical Equipment Disposables Co. (Oman)
Market Opportunities
Rising Prevalence of Eye Disorders and Aging Population
Technological Advancements and AI Integration
Value Added Data Infosets
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Middle East and Africa Ophthalmology Devices Market Trends
“Enhanced Convenience Through Technological Advancements”
A significant and accelerating trend in the global Middle East and Africa Ophthalmology Devices Market is the continuous development of advanced imaging systems, diagnostic technologies, and minimally invasive surgical solutions, which are significantly improving clinical efficiency, patient outcomes, and accessibility to care
For instance, advanced optical coherence tomography (OCT) and high-resolution fundus imaging devices allow clinicians to detect ocular diseases at early stages, including glaucoma, macular degeneration, and diabetic retinopathy. Similarly, femtosecond lasers and micro-incision surgical platforms enhance procedural precision while reducing recovery times, offering a discreet and highly effective ophthalmic solution
Integration of portable and point-of-care ophthalmic devices enables clinicians to provide reliable screening and monitoring in remote and underserved areas, supporting faster diagnosis and follow-ups without compromising quality
The adoption of clinician-friendly, ergonomically designed devices with multi-functional capabilities is facilitating workflow efficiency, reducing examination times, and enhancing patient experiences
This focus on technological innovation, improved usability, and enhanced clinical outcomes is fundamentally reshaping expectations for ophthalmic care. Consequently, companies such as Topcon, Carl Zeiss Meditec, and Alcon are developing solutions that combine precision, reliability, and ease of use for both diagnostic and surgical applications
The demand for advanced ophthalmology devices is growing rapidly across hospitals, clinics, and specialty centers worldwide, as healthcare providers increasingly prioritize diagnostic accuracy, patient safety, and procedural efficiency
Middle East and Africa Ophthalmology Devices Market Dynamics
Driver
“Growing Demand for Advanced Diagnostics and Minimally Invasive Surgeries”
The increasing prevalence of ocular disorders, including cataract, glaucoma, diabetic retinopathy, and macular degeneration, is driving the adoption of high-precision diagnostic and surgical ophthalmology devices
For instance, in April 2024, Topcon Medical Systems launched an advanced OCT platform with enhanced imaging speed and improved retinal layer visualization, enabling earlier diagnosis and optimized treatment planning. Such initiatives by leading companies are expected to propel market growth in the forecast period
Healthcare providers are actively adopting minimally invasive surgical technologies and high-resolution imaging devices to improve procedural accuracy, reduce complications, and enhance patient outcomes
Furthermore, the growing emphasis on point-of-care diagnostics and portable devices is expanding access to ophthalmic care, particularly in emerging markets and remote regions, contributing to overall market expansion
The combination of advanced technology, improved workflow, and patient-centric design is a key factor driving the adoption of ophthalmology devices across hospitals, clinics, and specialty care centers
Restraint/Challenge
“High Costs and Limited Accessibility in Emerging Markets”
The high capital investment required for advanced ophthalmology devices, including imaging systems and surgical platforms, remains a major barrier to adoption, particularly for smaller clinics and healthcare facilities in developing regions
For instance, premium devices from companies such as Carl Zeiss Meditec and Alcon may be cost-prohibitive for resource-limited hospitals or clinics
In addition, limited availability of trained personnel to operate sophisticated equipment and provide follow-up care can hinder broader market penetration
Addressing these challenges through cost-effective, multi-functional, and portable device solutions, as well as investing in clinician training programs, is essential to drive adoption and expand market reach
Although prices for mid-range and portable ophthalmology devices are gradually decreasing, perceived high costs and accessibility limitations continue to restrict widespread utilization, particularly in underdeveloped and rural regions
Middle East and Africa Ophthalmology Devices Market Scope
The market is segmented on the basis of product type, application, and end user.
• By Product Type
On the basis of product type, the Middle East and Africa Ophthalmology Devices Market is segmented into Vision Care Devices, Surgery Devices, and Diagnostic and Monitoring Devices. The Diagnostic and Monitoring Devices segment dominated the largest market revenue share of 46.7% in 2024, driven by the growing prevalence of eye disorders such as glaucoma, cataract, and diabetic retinopathy which require continuous monitoring and early-stage detection. Increasing utilization of advanced imaging technologies including optical coherence tomography (OCT), fundus cameras, and wavefront aberrometers has further enhanced diagnostic precision. The integration of artificial intelligence (AI) in ophthalmic diagnostics has enabled faster image analysis, reducing diagnostic errors and improving clinical outcomes. Furthermore, the adoption of teleophthalmology platforms in hospitals and clinics has expanded access to remote eye diagnostics, particularly across rural and underserved areas. The presence of well-established healthcare infrastructure and favorable reimbursement policies in the U.S. and Europe continues to support high product demand. In addition, the rising focus on early detection programs and preventive eye health awareness initiatives has significantly bolstered device installations. The growing aging population and lifestyle-induced vision impairments are further expected to propel the diagnostic device segment’s growth trajectory. Increasing R&D investments by global players for innovation in portable and AI-assisted devices are enhancing global accessibility and affordability. Overall, the diagnostic and monitoring devices segment remains the key contributor to market expansion due to its essential role in accurate disease identification and management.
The Surgery Devices segment is anticipated to witness the fastest growth rate of 10.8% from 2025 to 2032, driven by the increasing number of ophthalmic surgeries, especially cataract, glaucoma, and refractive procedures. The introduction of robotic-assisted systems, femtosecond laser technologies, and disposable microsurgical instruments has transformed ophthalmic surgical efficiency and safety. Surgeons are increasingly adopting minimally invasive and laser-assisted techniques that provide faster recovery times and superior visual outcomes for patients. Growing access to healthcare and medical tourism in emerging economies such as India, Singapore, and the UAE is also boosting ophthalmic surgical volumes. The shift from traditional manual surgery to digital and image-guided procedures is enhancing precision and reducing surgical risks. In addition, the availability of premium intraocular lenses (IOLs) and micro-incision phacoemulsification systems is expanding adoption in high-income and middle-income regions alike. Strong collaborations between medical device companies and hospitals for technology transfer and skill development are further supporting rapid growth. Rising patient awareness of elective vision correction surgeries, such as LASIK and SMILE, is another factor driving the expansion of this segment. Continuous innovations focused on cost-effectiveness and automation are making advanced surgical technologies more accessible. Hence, the surgery devices segment is expected to record substantial growth momentum throughout the forecast period.
• By Application
On the basis of application, the Middle East and Africa Ophthalmology Devices Market is segmented into Vision Care, Ophthalmic Woundcare, Cataract Surgery, Oculoplastics, and Others. The Vision Care segment held the largest market revenue share of 42.1% in 2024, primarily attributed to the high global prevalence of refractive errors such as myopia, hyperopia, and astigmatism. Increasing digital screen exposure, aging populations, and growing demand for contact lenses and prescription spectacles have driven continuous demand. The segment benefits from product innovations like smart contact lenses, anti-fatigue coatings, and blue light filtering lenses designed to reduce eye strain from electronic devices. Furthermore, the expansion of e-commerce platforms and retail optical chains has increased the accessibility and affordability of vision care products. Major players are focusing on eco-friendly materials and extended-wear contact lenses to enhance comfort and sustainability. Regular eye check-up campaigns by public health organizations and the World Health Organization’s (WHO) initiatives for vision correction have boosted awareness. Technological integration in optometry, including digital lens fitting and AI-powered eye exams, has improved accuracy and customization for patients. The rising use of daily disposable contact lenses and customized frames among youth further supports segment dominance. Partnerships between optical manufacturers and healthcare providers are enhancing product penetration globally. Thus, the vision care segment continues to be the backbone of the ophthalmology devices industry, sustaining consistent revenue streams.
The Cataract Surgery segment is projected to witness the fastest CAGR of 11.3% from 2025 to 2032, driven by the growing incidence of cataracts among the elderly population and the increasing availability of advanced intraocular lens technologies. The shift toward femtosecond laser-assisted cataract surgery has significantly improved precision and safety in surgical procedures. Technological advancements such as toric and multifocal intraocular lenses (IOLs) provide enhanced visual outcomes and patient satisfaction, reducing the dependency on spectacles post-surgery. Moreover, the rising affordability of cataract procedures in developing economies due to government-led health initiatives is boosting surgery volumes. For instance, national vision restoration programs in India and Africa are facilitating free or subsidized cataract operations, improving accessibility. The growing geriatric population in both developed and emerging countries is another major growth driver. Increasing collaborations between research institutes and device manufacturers have led to continuous product innovation and customization in lens materials. In addition, robotic-assisted cataract surgeries are being increasingly adopted across major hospitals in North America and Europe. The strong focus on reducing surgery time, minimizing complications, and enhancing patient recovery continues to push technological integration in this segment. Consequently, the cataract surgery application is set to lead future market expansion with strong innovation and volume growth.
• By End User
On the basis of end user, the Middle East and Africa Ophthalmology Devices Market is segmented into Hospitals, Diagnosis Clinics, Franchise Optical Stores, Eye Research Institutes, and Government Agencies and Academics. The Hospitals segment accounted for the largest market revenue share of 48.5% in 2024, as hospitals serve as the central hubs for both ophthalmic diagnostics and surgical interventions. The high patient inflow for cataract, refractive, and glaucoma treatments drives significant device utilization across hospital settings. Advanced imaging systems, operating microscopes, and surgical platforms are increasingly being adopted in multispecialty and specialty eye hospitals. Hospitals benefit from established infrastructure, multidisciplinary expertise, and the integration of electronic health records (EHRs) that streamline patient management and follow-up. The segment also gains from high investment capacity for technologically advanced diagnostic tools and surgical equipment. Rising healthcare expenditure and hospital accreditation initiatives in developing economies have further supported modern ophthalmology infrastructure. The increasing trend of day-care ophthalmic surgeries in hospital-affiliated centers is boosting equipment demand. In addition, collaborations between hospitals and major manufacturers for device trials and innovation programs continue to drive product availability and adoption. Hospitals also lead in clinical research and training programs that promote the latest ophthalmic technologies, cementing their dominant market position.
The Diagnosis Clinics segment is projected to record the fastest CAGR of 9.9% from 2025 to 2032, driven by the growing number of standalone ophthalmic and optometric centers specializing in diagnostic services. The emergence of miniaturized diagnostic devices has enabled clinics to provide high-quality care with compact, cost-effective setups. Rising patient preference for personalized, quick, and localized diagnostic services is fueling demand for independent clinics. These clinics offer shorter waiting times, specialized consultations, and advanced testing such as OCT, retinal imaging, and corneal topography. Increased awareness regarding early detection of vision disorders and the rising prevalence of diabetic eye diseases have expanded clinic visits. Integration of teleophthalmology and AI-based platforms allows remote diagnosis and consultation, improving accessibility in suburban and rural areas.
Middle East and Africa Ophthalmology Devices Market Regional Analysis
The Middle East & Africa Middle East and Africa Ophthalmology Devices Market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by increasing healthcare investments, modernization of hospitals and clinics, and growing adoption of advanced ophthalmic diagnostic and surgical devices
Rising awareness about eye health, coupled with government initiatives promoting specialized eye care services, is encouraging the adoption of innovative ophthalmology technologies
The region is witnessing significant growth across hospitals, diagnostic centers, and specialized eye clinics, with key players investing in both new installations and upgrades of existing facilities
Saudi Arabia Middle East and Africa Ophthalmology Devices Market Insight
The Saudi Arabia Middle East and Africa Ophthalmology Devices Market dominated the region with the largest revenue share of 47.7% in 2024, driven by advanced healthcare infrastructure, high adoption of digital ophthalmic technologies, and a strong presence of key industry players. The country has witnessed substantial growth in ophthalmology device installations across hospitals, specialized eye clinics, and diagnostic centers. Increasing government focus on healthcare modernization, expansion of private eye care facilities, and rising prevalence of visual disorders further support market dominance. Additionally, collaborations between local hospitals and international ophthalmology device manufacturers are strengthening technology penetration and accessibility.
U.A.E. Middle East and Africa Ophthalmology Devices Market Insight
The U.A.E. Middle East and Africa Ophthalmology Devices Market is expected to be the fastest-growing country in the region during the forecast period, with a CAGR of 9.8% from 2025 to 2032. This growth is fueled by rising healthcare investments, modernization of hospitals and clinics, and adoption of advanced ophthalmic diagnostic and surgical devices. The country’s emphasis on medical tourism, expansion of specialized eye care centers, and initiatives supporting digital health integration are driving demand. Increasing awareness of eye health, coupled with growing access to advanced ophthalmology solutions, is encouraging hospitals and private clinics to adopt state-of-the-art devices. Partnerships between healthcare providers and global ophthalmology technology companies are also contributing to rapid market growth.
Middle East and Africa Ophthalmology Devices Market Share
The Ophthalmology Devices industry is primarily led by well-established companies, including:
Alcon Inc. (Switzerland)
Bausch + Lomb (U.S.)
Johnson & Johnson and its affiliates. (U.S.)
Carl Zeiss Meditec AG (Germany)
EssilorLuxottica (France)
Santen Pharmaceutical (U.A.E.)
Acuotech Egypt Ltd. (Egypt)
Optaline Medical Devices (Egypt)
SERVImed Industrial (Italy)
Al Shidhani Medical Equipment Disposables Co. (Oman)
Latest Developments in Middle East and Africa Ophthalmology Devices Market
In April 2023, Bausch + Lomb, a leading provider of eye care products, announced the acquisition of a portfolio of eye care products from Novartis for USD 1.75 billion. This acquisition includes the anti-inflammation eye drop, Xiidra, and the rights to AccuStream, a device for delivering treatments for dry eye disease. The deal is expected to expand Bausch + Lomb's range of offerings for eye conditions and be financially advantageous immediately. The transaction is set to be completed by the end of 2023
In May 2024, Merck announced its acquisition of Eyebiotech, a biotechnology company specializing in ophthalmology, for up to USD 3 billion. The deal entails an initial payment of USD 1.3 billion, with potential additional payments if developmental, regulatory, and commercial milestones are achieved. Eyebiotech is developing a drug called Restoret to treat vision loss. This acquisition aims to diversify Merck's product pipeline, particularly as it anticipates a decline in revenue from its current leading cancer drug, Keytruda, when its patent expires in 2028
In August 2025, EssilorLuxottica, the Franco-Italian maker of Ray-Ban, announced plans to acquire Optegra, an AI-focused ophthalmology platform, from MidEuropa. This acquisition enhances EssilorLuxottica’s portfolio, which already includes frames, lenses, wearables, AI-powered technologies, and medical instruments. Optegra operates more than 70 eye hospitals and diagnostic centers across the UK, Czech Republic, Poland, Slovakia, and the Netherlands, offering ophthalmic treatments and vision correction procedures that integrate AI in pre- and post-operative care. The acquisition is expected to close later in 2025, pending regulatory approval
In September 2025, Carl Zeiss Meditec issued a profit warning, causing its shares to fall by 13%. The company cited weak sales and earnings amid a drop in orders, particularly in North America, and a slow start to the peak season for refractive surgeries in China. Despite these challenges, Carl Zeiss expects renewed growth in fiscal 2025 and maintains its target of achieving an EBIT margin above 20%
SKU-28492
Get online access to the report on the World's First Market Intelligence Cloud
Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
Claudio Rondena
Group Business Development & Strategic Marketing Director, C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice.
Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough.
Your work is much appreciated.
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics,
Ipsen Biopharm Limited
We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.
Competition Analyst,
Basler Web
I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.
Marketing Director,
Buhler Group
It was indeed a good experience, would definitely recommend and come back for future prospects.
COO,
A global leader providing Drug Delivery Services
DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.
Marketing Director,
Philips Healthcare
The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.
Product manager,
Fujifilms
Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.
Investor relations,
GE Healthcare
Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.
Market Analyst,
Medincell
We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.
Andrew - Senior Global Marketing Manager,
Medtronic (US)
I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.
Amarildo - Manager, Global Strategic Alignment
MasterCard
We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.
Tor Hammer
Green Nexus LLc
Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects
I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying.
Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.
Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)
Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future